http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 06 Mar 2026 16:21:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Absci+Corp++++++++++++++++For%3A+Mar+03/26125771.html si-local-file:///var/storage/secattach/20260306/26125771.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Absci+Corp++++++++++++++++For%3A+Mar+03/26125771.html Fri, 06 Mar 2026 16:21:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Absci+Corp++++++++++++++++For%3A+Mar+03/26125771.html si-local-file:///var/storage/secattach/20260306/26125771.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Absci+Corp++++++++++++++++For%3A+Mar+03/26125771.html Fri, 06 Mar 2026 16:21:00 -0500 ABSI O.51016270 http://www.streetinsider.com/Press+Releases/Absci+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26125307.html <p align="justify">VANCOUVER, Wash. and NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced that on March 3, 2026, the company granted a non-statutory stock option to purchase an aggregate of 650,000 shares of its common stock to Dr. Ransi Somaratne in connection with his employment as Absci’s Chief Medical Officer. The inducement grant was previously approved by the Compensation Committee of Absci’s Board of Directors pursuant to Absci’s 2023 Inducement Plan (the “Inducement Plan”), and is being made as an inducement material http://www.streetinsider.com/Press+Releases/Absci+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26125307.html Fri, 06 Mar 2026 16:05:00 -0500 ABSI http://www.streetinsider.com/Globe+Newswire/Absci+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26125307.html <p align="justify">VANCOUVER, Wash. and NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced that on March 3, 2026, the company granted a non-statutory stock option to purchase an aggregate of 650,000 shares of its common stock to Dr. Ransi Somaratne in connection with his employment as Absci’s Chief Medical Officer. The inducement grant was previously approved by the Compensation Committee of Absci’s Board of Directors pursuant to Absci’s 2023 Inducement Plan (the “Inducement Plan”), and is being made as an inducement material http://www.streetinsider.com/Globe+Newswire/Absci+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26125307.html Fri, 06 Mar 2026 16:05:00 -0500 ABSI http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Pangalos+Menelas+N/26120845.html si-local-file:///var/storage/secattach/20260305/26120845.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Pangalos+Menelas+N/26120845.html Thu, 05 Mar 2026 18:57:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Pangalos+Menelas+N/26120845.html si-local-file:///var/storage/secattach/20260305/26120845.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Pangalos+Menelas+N/26120845.html Thu, 05 Mar 2026 18:57:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Walker+Shelby+J./26113716.html si-local-file:///var/storage/secattach/20260304/26113716.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Walker+Shelby+J./26113716.html Wed, 04 Mar 2026 21:14:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Walker+Shelby+J./26113716.html si-local-file:///var/storage/secattach/20260304/26113716.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Walker+Shelby+J./26113716.html Wed, 04 Mar 2026 21:14:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Bedrick+Todd/26113708.html si-local-file:///var/storage/secattach/20260304/26113708.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Bedrick+Todd/26113708.html Wed, 04 Mar 2026 21:05:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Bedrick+Todd/26113708.html si-local-file:///var/storage/secattach/20260304/26113708.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Bedrick+Todd/26113708.html Wed, 04 Mar 2026 21:05:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+McClain+Sean/26113709.html si-local-file:///var/storage/secattach/20260304/26113709.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+McClain+Sean/26113709.html Wed, 04 Mar 2026 21:05:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+McClain+Sean/26113709.html si-local-file:///var/storage/secattach/20260304/26113709.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+McClain+Sean/26113709.html Wed, 04 Mar 2026 21:05:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+03++Filed+by%3A+Busch+Andreas/26113702.html si-local-file:///var/storage/secattach/20260304/26113702.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+03++Filed+by%3A+Busch+Andreas/26113702.html Wed, 04 Mar 2026 21:04:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+03++Filed+by%3A+Busch+Andreas/26113702.html si-local-file:///var/storage/secattach/20260304/26113702.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+03++Filed+by%3A+Busch+Andreas/26113702.html Wed, 04 Mar 2026 21:04:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Jonasson+Zachariah/26113703.html si-local-file:///var/storage/secattach/20260304/26113703.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Jonasson+Zachariah/26113703.html Wed, 04 Mar 2026 21:04:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Jonasson+Zachariah/26113703.html si-local-file:///var/storage/secattach/20260304/26113703.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Jonasson+Zachariah/26113703.html Wed, 04 Mar 2026 21:04:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Jonasson+Zachariah/26101897.html si-local-file:///var/storage/secattach/20260303/26101897.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Jonasson+Zachariah/26101897.html Tue, 03 Mar 2026 16:24:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Jonasson+Zachariah/26101897.html si-local-file:///var/storage/secattach/20260303/26101897.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Mar+02++Filed+by%3A+Jonasson+Zachariah/26101897.html Tue, 03 Mar 2026 16:24:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Absci+Corp++++++++++++++++For%3A+Feb+02++Filed+by%3A+McClain+Sean/26101636.html si-local-file:///var/storage/secattach/20260303/26101636.html http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Absci+Corp++++++++++++++++For%3A+Feb+02++Filed+by%3A+McClain+Sean/26101636.html Tue, 03 Mar 2026 16:18:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Absci+Corp++++++++++++++++For%3A+Feb+02++Filed+by%3A+McClain+Sean/26101636.html si-local-file:///var/storage/secattach/20260303/26101636.html http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Absci+Corp++++++++++++++++For%3A+Feb+02++Filed+by%3A+McClain+Sean/26101636.html Tue, 03 Mar 2026 16:18:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Feb+27++Filed+by%3A+Pangalos+Menelas+N/26101668.html si-local-file:///var/storage/secattach/20260303/26101668.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Feb+27++Filed+by%3A+Pangalos+Menelas+N/26101668.html Tue, 03 Mar 2026 16:18:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Feb+27++Filed+by%3A+Pangalos+Menelas+N/26101668.html si-local-file:///var/storage/secattach/20260303/26101668.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Absci+Corp++++++++++++++++For%3A+Feb+27++Filed+by%3A+Pangalos+Menelas+N/26101668.html Tue, 03 Mar 2026 16:18:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Absci+Corp++++++++++++++++For%3A+Feb+02++Filed+by%3A+Jonasson+Zachariah/26101673.html si-local-file:///var/storage/secattach/20260303/26101673.html http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Absci+Corp++++++++++++++++For%3A+Feb+02++Filed+by%3A+Jonasson+Zachariah/26101673.html Tue, 03 Mar 2026 16:18:00 -0500 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Absci+Corp++++++++++++++++For%3A+Feb+02++Filed+by%3A+Jonasson+Zachariah/26101673.html si-local-file:///var/storage/secattach/20260303/26101673.html http://www.streetinsider.com/SEC+Filings/Form++4A++++++++Absci+Corp++++++++++++++++For%3A+Feb+02++Filed+by%3A+Jonasson+Zachariah/26101673.html Tue, 03 Mar 2026 16:18:00 -0500 ABSI O.51016270 http://www.streetinsider.com/Management+Changes/Absci+appoints+Ransi+Somaratne+as+chief+medical+officer/26096719.html <p>Absci Corporation (NASDAQ: ABSI) appointed Ransi Somaratne as chief medical officer to lead clinical development of its AI-designed therapeutics pipeline, the company announced.</p> <p>Somaratne joins from Vertex Pharmaceuticals, where he served as senior vice president of clinical development. He previously held scientific leadership roles at BioMarin Pharmaceutical and Amgen.</p> <p>The cardiologist and internist has worked on clinical development programs including hemophilia A gene therapy Roctavian, PCSK9 inhibitor Repatha, and NaV1.8 inhibitor Journavx. He earned his medical degree from Albany Medical College and holds an MBA from the University of North Carolina at Chapel Hill.</p> <p>Absci also announced the retirement of Chief Innovation Officer http://www.streetinsider.com/Management+Changes/Absci+appoints+Ransi+Somaratne+as+chief+medical+officer/26096719.html Tue, 03 Mar 2026 08:00:12 -0500 ABSI